Top list · Europe
19 AI drug discovery startups in Europe have raised money in rounds we track. These are the 19 that have raised the most, $3.5B between them, with the United Kingdom the most common home.
Isomorphic Labs is a London-based artificial intelligence company focused on transforming the drug discovery process.
Founded 2021London, United Kingdom$3.1Blast round May 2026BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
Founded 2013United Kingdom$205Mlast round Sept 2019Genomics Ltd, founded in 2014 in Oxford, UK, is a global techbio and precision medicine company.
Founded 2014Oxford, United Kingdom$93Mlast round Jan 2024CoSyne Therapeutics is an AI-driven drug discovery company based in London, UK, founded in 2021.
Founded 2021London, United Kingdom$24Mlast round Jul 2026VRG Tx is technology-driven biotech with a drug discovery platform that integrates AI with wet lab processes to develop next-generation therapeutics.
Founded 2023Budapest, Hungary$21Mlast round Feb 2024Multiomic Health is an AI-enabled drug discovery company founded in 2021 and based in London, United Kingdom.
Founded 2021London, United Kingdom$14Mlast round Jul 2026RECEPTOR.AI - drug discovery for precision medecine
Founded 2021London, United Kingdom$11Mlast round Nov 2024DaltonTx is a UK-based biotechnology and healthcare IT company founded in 2024.
Founded 2024London, United Kingdom$11Mlast round Sept 2025DeepLife is a French AI techbio company founded in 2019, specializing in drug discovery through its innovative SaaS platform.
Founded 2019Paris, France$10Mlast round Dec 2024PharmEnable Therapeutics is a private drug discovery biotechnology company based in Cambridge, UK, founded in 2016 as a spin-out from the University of Cambridge.
Founded 2016Cambridge, United Kingdom$7.5Mlast round Dec 2023Ignota Labs is an AI-driven drug discovery and revitalization company based in Cambridge, United Kingdom.
Founded 2021Cambridge, United Kingdom$7.2Mlast round Feb 2025Iktos is a deep learning technology platform focused on new drug design and discovery.
Founded 2016Paris, France$2.6Mlast round Feb 2025Ariana Pharma is a French biotechnology company founded in 2003, specializing in AI-driven drug development.
Founded 2003Paris, France$2.3Mlast round Jul 2008Kiin Bio, legally known as Kiin AI Limited, is a UK-based artificial intelligence company focused on AI-driven drug discovery and biological research.
Founded 2024London, United Kingdom$2.2Mlast round Jun 2025molecule.one is an AI-driven biotechnology company focused on autonomous chemical synthesis and drug discovery.
Founded 2019San Francisco, Poland$1.0Mlast round Jun 2025Revolutionizing neurology diagnostics and drug discovery with Artificial Intelligence.
Founded 2021Cambridge, United Kingdom$935Klast round Dec 2022PentaBind uses Generative AI and aptamers for innovative drug discovery and diagnostics in biotechnology.
Founded 2021United Kingdom$845Klast round Jan 2024Anyo Labs is an AI-driven biotechnology startup based in Gothenburg, Sweden, founded in December 2022.
Founded 2022Gothenburg, Sweden$444Klast round May 2024Lemna Bio is a biotech company based in Lausanne, Switzerland, that focuses on drug discovery through a physics-driven AI platform.
Founded -Lausanne, Switzerland$189Klast round Apr 2026Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back AI drug discovery startups in Europe in the app, with filters, lists and exports.
ILO
NHHealth startups in Europe3,025 companies · $29B
IL
NH
CSBiotech startups in Europe1,665 companies · $22B
NGBig data startups in Europe964 companies · $31B
V
S
CGEnergy providers startups in Europe953 companies · $41B
S
EP
SClimate tech startups in Europe756 companies · $25B
SK
FCFintech startups in Europe749 companies · $30B
A
CI
YCustomer service startups in Europe720 companies · $13BN
W
TTransport startups in Europe697 companies · $28B